evelyne_nguyen_nicox

Nicox makes two appointments

February 6, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NicOx, nguyen, nicolas

French pharma firm Nicox has hired Evelyne Nguyen to be its chief financial officer and Stéphane Nicolas joins its executive …

gsk image

GSK to make ‘fundamental changes’

February 6, 2014
Sales and Marketing China, GSK, Tafinlar, Witty, q4, results

GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …

Globe faces cancer ‘tidal wave’

February 5, 2014
Research and Development, Sales and Marketing Cancer, WHO, globe, world cancer report

The World Health Organisation has warned of a ‘tidal wave’ of cancer cases which it says will sweep across the …

National Institutes of Health image

Drug giants team up for Alzheimer’s

February 5, 2014
Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer

The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …

david_lockwood

Laird chief executive takes up key innovation role





February 5, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing david lockwood, laird

David Lockwood OBE has been appointed to an influential business innovation role in the UK as non-executive chair of the …

Three new entries to Cancer Drugs Fund

February 5, 2014
Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo

Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …

Cancer Research UK turns to gamification with app

February 4, 2014
Medical Communications, Sales and Marketing CRUK, Cancer, Gamification, genes in space

Cancer Research UK has launched a new citizen science game aimed at helping its scientists discover new cures for cancer. …

New Ashfield unit to meet pharma’s challenges

February 4, 2014
Medical Communications ashfield healthcare

Ashfield healthcare has created a new division to integrate its eight units into one business area offering in an effort …

Pfizer breast cancer drug shows promise

February 4, 2014
Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib

Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial.  The pill was administered …

Biogen Idec image

Biogen Idec’s MS drug gets European approval

February 4, 2014
Manufacturing and Production, Sales and Marketing Aubagio, Biogen IDEC, EU, MS, gilenya, tecdifera

Biogen Idec’s oral multiple sclerosis drug Tecfidera has won approval in Europe as a first-line treatment for people with relapsing-remitting …

Astrazeneca image

AstraZeneca ‘simplifies decision-making’

February 4, 2014
Sales and Marketing AstraZeneca, BMS, Byetta, Forxiga, Onglyza, diabetes

AstraZeneca has completed its $4.3 billion acquisition of Bristol-Myers Squibb’s diabetes business, giving the company control over several big-name brands …

sir michael parkinson image

Sir Michael Parkinson criticises NICE

February 4, 2014
Medical Communications, Sales and Marketing Astellas, NHS, NICE, Xtandi, parkinson, prostate

TV host Sir Michael Parkinson has told NICE that it must lift the restrictions imposed on Astellas’ new prostate cancer …

screen_shot_2014-02-04_at_08

Sartorius hires laboratory manager

February 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael Melingo, satorius

Lab and technology firm Sartorius has appointed Michael Melingo to be its laboratory manager. Melingo is to succeed Dominique Baly …

Roche image

Roche: NICE guidance ‘perverse’

February 4, 2014
Sales and Marketing NHS, NICE, NSCLC, Roche, Tarceva

Roche has poured scorn on NICE’s ‘perverse’ recommendation that its EGFR-TK inhibitor Tarceva should no longer be given to NHS …

J&J image

J&J reveals more on transparency policy

February 3, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda

Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …

Abbvie image

AbbVie ‘pleased’ with first year

February 3, 2014
Sales and Marketing AbbVie, Abbott, CLL, EMA, HIV, Humira

Rheumatoid arthritis treatment Humira – as expected – has driven AbbVie in its first year as a standalone company, accounting …

Scotland reforms will see drug access improve

February 3, 2014
Sales and Marketing PACE, SMC, Scotland, drugs, neil

Scotland is set to overhaul its medicines access system after complaints from charities and interest groups that patients have been …

Teva/VCCP on top at PM Society ad awards

February 3, 2014
Medical Communications, Sales and Marketing 2014, Teva, ads, advertising, neil smith, pm awards, vccp

Teva and its agency partner VCCP took home the most wins from this year’s PM Society Advertising Awards that featured …

CDF image

Cancer Drugs Fund: assessing a difficult legacy

February 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty

England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …

eddie_williams_novo

Novo Nordisk makes Eddie Williams senior VP

February 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, eddie williams

Novo Nordisk has promoted Eddie Williams to the position of senior vice president of its biopharmaceuticals unit. Williams brings three …

The Gateway to Local Adoption Series

Latest content